CURE Pharmaceutical Expands Cannabis Extraction Patents, Adding Support for CBG for Therapeutic Solutions

Equipment manufacturers, cannabis processors and drug developers can license CURE’s patented methods for optimal extraction of cannabinoids LOS ANGELES, April 21, 2020 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced the issuance of two U.S. Patents: No. 10,639,339 and 10,624,940. These patents represent an expansion of CURE’s existing “product by…